Bank of Montreal
CGEM icon

Bank of Montreal’s Cullinan Oncology CGEM Stock Holding History

Bank of Montreal’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-187,547
Closed -$2.48M – 3850
2023
Q2 		$2.48M Buy
+187,547
New +$1.99M ﹤0.01% 1691
2021
Q2 		– Sell
-399
Closed -$14K – 3873
2021
Q1 		$14K Buy
+399
New +$16.2K ﹤0.01% 4201

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Bank of Montreal's CGEM Position: Q3 2023 in Review

Bank of Montreal sold out of Cullinan Oncology (CGEM) in Q3 2023, closing a stake of 187,547 shares — an estimated $2.48M sold.

Bank of Montreal first reported a position in CGEM in Q1 2021 and held it in 2 quarters. The position peaked at $2.48M in Q2 2023. 106 funds tracked by Wall St. Rank hold CGEM as of Q3 2023.

  • Bank of Montreal reported no remaining Cullinan Oncology position as of Q3 2023 after selling out during the quarter.
  • Bank of Montreal sold 187,547 Cullinan Oncology shares in Q3 2023, an estimated $2.48M.
  • Bank of Montreal first reported a position in Cullinan Oncology in Q1 2021 and held it in 2 quarters.
  • Bank of Montreal's Cullinan Oncology position peaked at $2.48M in Q2 2023.
  • 106 funds tracked by Wall St. Rank held Cullinan Oncology as of Q3 2023.

Based on Bank of Montreal's 13F filing for Q3 2023, filed 1 Nov 2023.